Dr. Corey Casper is Chief Executive Officer of Banner Research, which transforms discoveries into new diagnostic, treatment and prevention methods for diseases such as Alzheimer’s, Parkinson’s, cardiovascular disease and cancer.

Dr. Corey Casper
CEO, Banner Research
Dr. Casper is a seasoned executive leader and physician-scientist who has designed and led numerous impactful research collaborations over his three-decade career.
- Founding chief executive officer of the Access to Advanced Health Institute in Seattle, a novel non-profit research institute that collaborates with academic and government partners and pharmaceutical companies to invent, develop, manufacture and license vaccines and immunotherapeutics.
- Founding director of the Global Oncology program at the Fred Hutch Cancer Center, responsible for building a preeminent international research, training and clinical care center and growing a new research and academic section.
- Previous positions include as a professor of medicine, epidemiology and global health at the University of Washington, where he was a co-director of the Center for AIDS Research, and an affiliate professor and associate cancer center director at the Fred Hutch Cancer Center.
Dr. Casper has led the development of more than two dozen products and made important gains in our understanding of the relationship between infection, immunity and cancer, Dr. Casper has served as the principal investigator on more than $100 million in grants and contracts and authored more than 130 peer-reviewed manuscripts.
A graduate of Cornell University Medical College in New York, he completed an internal medicine residency at the University of California – San Francisco. He received his Master of Public Health in epidemiology from the University of Washington, where he also completed his infectious disease fellowship.
Listen to Dr. Cory Casper’s recent interview on KJZZ.
Banner Health gets a new research chief as Trump threatens federal funding